Gorman Kevin Charlesinsider trades

In SEC Form 4 filings, Gorman Kevin Charles is listed as Director of Neurocrine Biosciences Inc (NBIX). Gorman Kevin Charles reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 15.

Companies and roles

Company	Role	Transactions	Last filed
NBIXNeurocrine Biosciences Inc	Director	2	Sep 15

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NBIXNeurocrine Biosciences Inc	Sep 11	Sep 15	A	14,343	$0.00	$0	525,636	No	Form 4
NBIXNeurocrine Biosciences Inc	Sep 11	Sep 15	F	7,839	$156.22	$1,224,609	517,797	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.